GÖRG advises Vink Chemicals on the acquisition of all shares in ISP Biochema Schwaben GmbH from Ashland group
A GÖRG team led by Dr. Frank Evers advises the German Vink Chemicals GmbH & Co. KG on the acquisition of all shares in ISP Biochema Schwaben GmbH from ISP Marl Holdings GmbH, a company of the US chemicals group Ashland.
Advisors Vink Chemicals GmbH & Co. KG
GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. Frank Evers, Partner, M&A / Corporate, Hamburg
Dr. Marcus Heinemann, Associated Partner, M&A / Corporate, Hamburg
Dr. Jan-Henric M. Punte, LL.M. (Hull), Associate, M&A / Corporate, Hamburg
Dr. Christoph Mönig, Partner, Real Estate, Hamburg
Dr. Frank Wilke, Partner, Employment Law, Cologne
About Vink Chemicals
Vink Chemicals GmbH & Co. KG was founded in 2011 and is specialized in the development and formulation of biocidal products and active substances. Furthermore, the company focuses on the trade with specialty chemicals and develops a modern warehouse for hazardous goods as well as manufacturing facilities for the production of biocidal products. The product development and the quality management take place in Vink’s own laboratory. Vink Chemicals has an excellent network and is therefore able to act worldwide.
Ashland Global Holdings Inc. (NYSE: ASH) is a premier global specialty chemicals company serving customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, con-struction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. At Ashland, they are approximately 4,000 passionate, tenacious employees – from renowned scientists and research chemists to talented engineers and plant operators – who thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries.